July 21,2025


Huizhou, China – JINGHAO Medical (Stock Code: 872925), the first and only FDA 510K & EU MDR certified hearing aid manufacturer listed in China, today unveiled its 30,000㎡ AI-driven production hub capable of outputting 150,000+ units monthly.

▶ Core Capabilities Demonstrated:

  • Vertical Tech Integration: Self-developed chips + IntriCon Hearing Health acquisition ensuring supply chain control
  • Brutal QC Protocol: 20-layer inspection with 50+ precision instruments
  • Certification Mastery: Assisted partners in obtaining AU/KR/BR local compliance

“Our flexible 200-unit MOQ breaks barriers for emerging brands,” “By combining automated production with in-house semiconductor tech..

  • 30,000㎡
  • AI-optimized factory space
  • 150K+/month
  • Production capacity
  • 0.1dB
  • Hearing test precision

Strategic Market Positioning

JINGHAO’s 2024 acquisition of IntriCon’s Hearing Health chip assets accelerates development of next-gen hearing solutions:
✓ Bluetooth-enabled OTC devices
✓ AI-driven soundscape adaptation
✓ Self-fitting programmable systems

2025 New Product Recommendation:

A49A:https://www.jhhearingaids.com/jh-a49a-mini-cic-digital-hearing-aids-over-the-counter-2025/
A26A:https://www.jhhearingaids.com/jh-a26a-invisible-in-ear-otc-hearing-aids-rechargeable-2025/

Link:Jinghao Medical Powers Global Hearing Aid Supply: FDA-510K Certified Factory


The article comes from the Internet. If there is any infringement, please contact service@jhhearingaids.com to delete it.